Carregant...
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
BACKGROUND: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum inhibit...
Guardat en:
| Publicat a: | BMC Microbiol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683470/ https://ncbi.nlm.nih.gov/pubmed/31382897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-019-1558-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|